文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

乳腺癌的现状和未来负担:2020 年和 2040 年全球统计数据。

Current and future burden of breast cancer: Global statistics for 2020 and 2040.

机构信息

Cancer Surveillance Branch, International Agency for Research on Cancer, Lyon, France.

Cancer Surveillance Branch, International Agency for Research on Cancer, Lyon, France.

出版信息

Breast. 2022 Dec;66:15-23. doi: 10.1016/j.breast.2022.08.010. Epub 2022 Sep 2.


DOI:10.1016/j.breast.2022.08.010
PMID:36084384
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9465273/
Abstract

BACKGROUND: Breast cancer is the most commonly diagnosed cancer worldwide, and its burden has been rising over the past decades. In this article, we examine and describe the global burden of breast cancer in 2020 and predictions for the year 2040. METHODS: Estimates of new female breast cancer cases and deaths in 2020 were abstracted from the GLOBOCAN database. Age-standardized incidence and mortality rates were calculated per 100,000 females by country, world region, and level of human development. Predicted cases and deaths were computed based on global demographic projections for the year 2040. RESULTS: Over 2.3 million new cases and 685,000 deaths from breast cancer occurred in 2020. Large geographic variation across countries and world regions exists, with incidence rates ranging from <40 per 100,000 females in some Asian and African countries, to over 80 per 100,000 in Australia/New Zealand, Northern America, and parts of Europe. Smaller geographical variation was observed for mortality; however, transitioning countries continue to carry a disproportionate share of breast cancer deaths relative to transitioned countries. By 2040, the burden from breast cancer is predicted to increase to over 3 million new cases and 1 million deaths every year because of population growth and ageing alone. CONCLUSION: Breast cancer is the most common cancer worldwide and continues to have a large impact on the global number of cancer deaths. Global efforts are needed to counteract its growing burden, especially in transitioning countries where incidence is rising rapidly, and mortality rates remain high.

摘要

背景:乳腺癌是全球最常见的癌症,其负担在过去几十年中一直在上升。本文旨在研究和描述 2020 年全球乳腺癌负担,并对 2040 年的情况进行预测。

方法:从 GLOBOCAN 数据库中提取 2020 年女性乳腺癌新发病例和死亡人数的估计值。按国家、世界区域和人类发展水平计算每 10 万名女性的年龄标准化发病率和死亡率。根据 2040 年全球人口预测计算预测病例和死亡人数。

结果:2020 年全球有超过 230 万例新发病例和 68.5 万例乳腺癌死亡。国家和世界区域之间存在较大的地理差异,发病率从某些亚洲和非洲国家的每 10 万女性<40 例到澳大利亚/新西兰、北美和欧洲部分地区的每 10 万女性超过 80 例不等。死亡率的地理差异较小;然而,转型国家乳腺癌死亡的负担相对于已转型国家仍不成比例。到 2040 年,仅由于人口增长和老龄化,乳腺癌负担预计每年将增加到 300 多万例新发病例和 100 多万例死亡。

结论:乳腺癌是全球最常见的癌症,继续对全球癌症死亡人数产生重大影响。需要全球共同努力来应对其不断增加的负担,特别是在发病率迅速上升且死亡率仍然较高的转型国家。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a1c/9465273/778ffb7d63d0/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a1c/9465273/c8e3c0439ecd/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a1c/9465273/086a9ef01906/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a1c/9465273/5184516a8de8/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a1c/9465273/778ffb7d63d0/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a1c/9465273/c8e3c0439ecd/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a1c/9465273/086a9ef01906/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a1c/9465273/5184516a8de8/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a1c/9465273/778ffb7d63d0/gr4.jpg

相似文献

[1]
Current and future burden of breast cancer: Global statistics for 2020 and 2040.

Breast. 2022-12

[2]
Current and future burden of breast cancer in Asia: A GLOBOCAN data analysis for 2022 and 2050.

Breast. 2025-2

[3]
Global burden of colorectal cancer in 2020 and 2040: incidence and mortality estimates from GLOBOCAN.

Gut. 2023-2

[4]
Global Burden of Cutaneous Melanoma in 2020 and Projections to 2040.

JAMA Dermatol. 2022-5-1

[5]
Global burden of gynaecological cancers in 2022 and projections to 2050.

J Glob Health. 2024-8-16

[6]
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.

CA Cancer J Clin. 2021-5

[7]
Global burden of primary liver cancer in 2020 and predictions to 2040.

J Hepatol. 2022-12

[8]
The current and future global burden of cancer among adolescents and young adults: a population-based study.

Lancet Oncol. 2024-12

[9]
Global patterns of breast cancer incidence and mortality: A population-based cancer registry data analysis from 2000 to 2020.

Cancer Commun (Lond). 2021-11

[10]
Global esophageal cancer epidemiology in 2022 and predictions for 2050: A comprehensive analysis and projections based on GLOBOCAN data.

Chin Med J (Engl). 2024-12-20

引用本文的文献

[1]
Association among Noncoding-RNAs, APRO Family Proteins, and Gut Microbiota in the Development of Breast Cancer.

Oncol Res. 2025-8-28

[2]
Berberine Sensitises Breast Cancer Cells to Radiation via the Attenuation of DNA Ligase III.

J Cell Mol Med. 2025-9

[3]
The impact of breast cancer awareness campaigns on the knowledge, attitudes, and practices of breast cancer screening among Saudi female employees.

PLoS One. 2025-9-5

[4]
Arjunolic Acid From Terminalia ivorensis A. Chev (Combretaceae) Possesses Anti-Breast Cancer Effects In Vitro and In Vivo.

Cancer Rep (Hoboken). 2025-9

[5]
Identification of potential hub genes and molecular mechanisms in breast cancer microenvironment: A comprehensive transcriptomics approach.

Medicine (Baltimore). 2025-8-29

[6]
Human papillomavirus-related syntaxin 11 reprograms tumor-associated macrophages to induce breast cancer cell apoptosis via PI3K/AKT signaling.

Mol Med. 2025-9-2

[7]
VisR Ultrasound Improves Diagnosis of Breast Cancer by the Elastogram-to-B-Mode Ratio in a Blinded Reader Study.

IEEE Open J Ultrason Ferroelectr Freq Control. 2025

[8]
The association between neighborhood socioeconomic status and breast cancer incidence and mortality risk: a large-scale cohort studies systematic review and meta-analysis.

Breast Cancer. 2025-8-30

[9]
Multidimensional evaluation of 3.0T HR-MRI, ultrasound imaging, and GATA3 protein expression in breast cancer, and their prognostic analysis.

Front Oncol. 2025-8-13

[10]
Evaluation of the Cytotoxic Activity of Nanostructured Lipid Carrier Systems for Fatty Acid Amides and Silk Fibroins in Breast Cancer Cell Lines.

Molecules. 2025-8-11

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索